Inactive Instrument
Eurofins-Cerep Stock Euronext Paris
Stocks
FR0012413771
Biotechnology & Medical Research
| Market Cap | 82.22M 94.58M 76.53M 70.26M 133M 9.03B 135M 902M 354M 4.49B 355M 347M 15.07B | P/E 2024 * |
-
| P/E 2025 | - |
|---|---|---|---|---|---|
| Enterprise Value | 61.18M 70.38M 56.95M 52.28M 98.74M 6.72B 100M 671M 263M 3.34B 264M 259M 11.22B | EV / Sales 2024 |
2.02x | EV / Sales 2025 | 1.67x |
| Free-Float |
4.22% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.01% |
| Manager | Title | Age | Since |
|---|---|---|---|
Damien Vielliard
CEO | Chief Executive Officer | - | 11/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Rodolphe Simonot
BRD | Director/Board Member | - | - |
Paul Ratcliffe
CHM | Chairman | - | 11/08/2023 |
Damien Vielliard
BRD | Director/Board Member | - | 23/05/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.01% | +4,900.50% | - | - | 94.58M | |
| -1.40% | +2.59% | -1.71% | +11.28% | 48.53B | |
| -2.41% | -0.90% | +403.17% | +614.40% | 39.87B | |
| -1.16% | +12.96% | +26.45% | +5.03% | 38.68B | |
| -1.88% | -3.03% | +4.94% | +47.52% | 35.13B | |
| -1.74% | +5.12% | +9.58% | +46.02% | 29.79B | |
| -2.85% | -3.92% | - | - | 16.08B | |
| -0.21% | -4.04% | +35.09% | +127.95% | 16.11B | |
| -0.64% | +2.65% | +1.25% | +8.92% | 13.61B | |
| -1.19% | -1.32% | -3.32% | -34.94% | 12.62B | |
| Average | -1.35% | +1.05% | +59.43% | +103.27% | 27.82B | |
| Weighted average by Cap. | -1.60% | +2.03% | +76.87% | +128.10% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 40.49M 46.58M 37.69M 34.6M 65.34M 4.45B 66.35M 444M 174M 2.21B 175M 171M 7.42B | 41.1M 47.28M 38.25M 35.12M 66.32M 4.51B 67.35M 451M 177M 2.25B 178M 174M 7.53B |
| Net income | 7.15M 8.23M 6.66M 6.11M 11.55M 786M 11.72M 78.5M 30.81M 391M 30.91M 30.23M 1.31B | 4.78M 5.5M 4.45M 4.09M 7.72M 525M 7.84M 52.47M 20.59M 261M 20.66M 20.21M 877M |
| Net Debt | -17.25M -19.85M -16.06M -14.74M -27.84M -1.89B -28.27M -189M -74.29M -943M -74.54M -72.9M -3.16B | -21.03M -24.2M -19.58M -17.98M -33.95M -2.31B -34.47M -231M -90.58M -1.15B -90.88M -88.88M -3.86B |
Employees
-
